1. Home
  2. BRID vs ACOG Comparison

BRID vs ACOG Comparison

Compare BRID & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgford Foods Corporation

BRID

Bridgford Foods Corporation

HOLD

Current Price

$7.69

Market Cap

72.8M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.27

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRID
ACOG
Founded
1932
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Specialty Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
72.8M
115.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BRID
ACOG
Price
$7.69
$6.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
2.8K
104.8K
Earning Date
01-28-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$227,364,000.00
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.24
$3.75
52 Week High
$10.83
$11.54

Technical Indicators

Market Signals
Indicator
BRID
ACOG
Relative Strength Index (RSI) 48.40 55.95
Support Level $7.26 $5.61
Resistance Level $8.50 $6.20
Average True Range (ATR) 0.25 0.57
MACD -0.06 0.10
Stochastic Oscillator 32.26 74.00

Price Performance

Historical Comparison
BRID
ACOG

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: